Cargando…
Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors
BACKGROUND: Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[(18)F]fluoro‐D‐glucose positron emission tomography/computed tomography ([(18)F] FDG‐PET/CT) may be...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447168/ https://www.ncbi.nlm.nih.gov/pubmed/37442801 http://dx.doi.org/10.1111/1759-7714.15032 |
_version_ | 1785094495766839296 |
---|---|
author | Rizzo, Alessio Cantale, Ornella Mogavero, Andrea Garetto, Lucia Racca, Manuela Venesio, Tiziana Anpalakhan, Shobana Novello, Silvia Gregorc, Vanesa Banna, Giuseppe Luigi |
author_facet | Rizzo, Alessio Cantale, Ornella Mogavero, Andrea Garetto, Lucia Racca, Manuela Venesio, Tiziana Anpalakhan, Shobana Novello, Silvia Gregorc, Vanesa Banna, Giuseppe Luigi |
author_sort | Rizzo, Alessio |
collection | PubMed |
description | BACKGROUND: Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[(18)F]fluoro‐D‐glucose positron emission tomography/computed tomography ([(18)F] FDG‐PET/CT) may be used as a marker of inflammation by measuring glucose metabolism in different colonic sites. METHODS: This retrospective analysis aimed to investigate the correlation between [(18)F] FDGPET/CT SUV(ratio) in six gastrointestinal districts, the spleen, the pharynx and the larynx alongside the most avid tumor lesion with peripheral blood inflammatory indexes, including the neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammatory index (SII, i.e., NLR times platelets) and lactate dehydrogenase (LDH), in patients with [(18)F] FDG‐PET/CT staged IV NSCLC who received first‐line immune checkpoint inhibitors (ICIs). The role of SUV(ratios) and peripheral blood inflammatory indexes in predicting overall survival (OS) and progression‐free survival (PFS) was then explored. RESULTS: A total of 43 patients were treated with first‐line ICI alone (58%) or in combination with chemotherapy (42%). A significant correlation was only found between the rectosigmoid SUV(ratio) and NLR (p = 0.0465). NLR >5.5 and LDH > 333.5 were associated with a worse OS (p = 0.033 and p = 0.009, respectively). The SII was associated with a worse PFS in patients treated with ICI alone (p = 0.033). None of the SUV(ratios) were significantly associated with OS or PFS, although a high left colon SUV(ratio) showed a trend toward a worse PFS. CONCLUSION: There was no significant correlation between [(18)F]FDG PET/CT uptake in different anatomical sites, and in the tumor, and systemic immune‐inflammatory indexes. The prognostic role of high left colon SUV(ratio) deserves further investigation. |
format | Online Article Text |
id | pubmed-10447168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-104471682023-08-24 Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors Rizzo, Alessio Cantale, Ornella Mogavero, Andrea Garetto, Lucia Racca, Manuela Venesio, Tiziana Anpalakhan, Shobana Novello, Silvia Gregorc, Vanesa Banna, Giuseppe Luigi Thorac Cancer Original Articles BACKGROUND: Inflammation in non‐small cell lung cancer (NSCLC) may impair the response to immune checkpoint inhibitors (ICIs) and can be indicated by peripheral blood inflammatory indexes. 2‐deoxy‐2‐[(18)F]fluoro‐D‐glucose positron emission tomography/computed tomography ([(18)F] FDG‐PET/CT) may be used as a marker of inflammation by measuring glucose metabolism in different colonic sites. METHODS: This retrospective analysis aimed to investigate the correlation between [(18)F] FDGPET/CT SUV(ratio) in six gastrointestinal districts, the spleen, the pharynx and the larynx alongside the most avid tumor lesion with peripheral blood inflammatory indexes, including the neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammatory index (SII, i.e., NLR times platelets) and lactate dehydrogenase (LDH), in patients with [(18)F] FDG‐PET/CT staged IV NSCLC who received first‐line immune checkpoint inhibitors (ICIs). The role of SUV(ratios) and peripheral blood inflammatory indexes in predicting overall survival (OS) and progression‐free survival (PFS) was then explored. RESULTS: A total of 43 patients were treated with first‐line ICI alone (58%) or in combination with chemotherapy (42%). A significant correlation was only found between the rectosigmoid SUV(ratio) and NLR (p = 0.0465). NLR >5.5 and LDH > 333.5 were associated with a worse OS (p = 0.033 and p = 0.009, respectively). The SII was associated with a worse PFS in patients treated with ICI alone (p = 0.033). None of the SUV(ratios) were significantly associated with OS or PFS, although a high left colon SUV(ratio) showed a trend toward a worse PFS. CONCLUSION: There was no significant correlation between [(18)F]FDG PET/CT uptake in different anatomical sites, and in the tumor, and systemic immune‐inflammatory indexes. The prognostic role of high left colon SUV(ratio) deserves further investigation. John Wiley & Sons Australia, Ltd 2023-07-13 /pmc/articles/PMC10447168/ /pubmed/37442801 http://dx.doi.org/10.1111/1759-7714.15032 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Rizzo, Alessio Cantale, Ornella Mogavero, Andrea Garetto, Lucia Racca, Manuela Venesio, Tiziana Anpalakhan, Shobana Novello, Silvia Gregorc, Vanesa Banna, Giuseppe Luigi Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors |
title | Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors |
title_full | Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors |
title_fullStr | Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors |
title_full_unstemmed | Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors |
title_short | Assessing the role of colonic and other anatomical sites uptake by [(18)F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors |
title_sort | assessing the role of colonic and other anatomical sites uptake by [(18)f]fdg‐pet/ct and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447168/ https://www.ncbi.nlm.nih.gov/pubmed/37442801 http://dx.doi.org/10.1111/1759-7714.15032 |
work_keys_str_mv | AT rizzoalessio assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT cantaleornella assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT mogaveroandrea assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT garettolucia assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT raccamanuela assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT venesiotiziana assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT anpalakhanshobana assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT novellosilvia assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT gregorcvanesa assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors AT bannagiuseppeluigi assessingtheroleofcolonicandotheranatomicalsitesuptakeby18ffdgpetctandimmuneinflammatoryperipheralbloodindexesinpatientswithadvancednonsmallcelllungcancertreatedwithfirstlineimmunecheckpointinhibitors |